Boschesi Barros, Vivian
Chiavegatto Filho, Alexandre Dias Porto
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (308731/2018-2)
São Paulo Research Foundation (17/09369-8)
Article History
Received: 29 July 2025
Accepted: 27 January 2026
First Online: 24 February 2026
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki and is registered in the UK Biobank system under application number 30140. The UK Biobank was approved by the North West Multi-centre Research Ethics Committee (reference number: 11/NW/0382) [ ]. Its main founders and sponsors are the Wellcome Charity and the Medical Research Council [ ]. UK Biobank participants are volunteers who signed an informed consent form before any study procedure [ ].
: Not applicable.
: Author VBB has worked at Axsome Therapeutics Inc. since 2022 supporting products in the psychiatry and neurology therapeutic areas and has received stock ownership from the latter. Author ADPCF declares that he has no competing interests.